ScholarGate
Assistant

Herpes Simplex Virus and HIV in Adolescents

Herpes simplex virus (HSV) and the human immunodeficiency virus (HIV) are chronic, lifelong viral sexually transmitted infections relevant to adolescent health. Genital HSV causes recurrent, often subclinical disease and establishes lifelong latency, while HIV causes progressive immune impairment unless treated. The two are biologically linked, as genital herpes increases susceptibility to and transmission of HIV. This topic describes both infections and the prevention strategies, including antiretroviral pre-exposure prophylaxis, that bear on adolescents.

Definition

Genital herpes is chronic infection with herpes simplex virus (types 1 or 2) producing recurrent anogenital lesions and lifelong latency; HIV infection is infection with the human immunodeficiency virus, which progressively depletes CD4 T-cells and, untreated, leads to acquired immunodeficiency.

Scope

The topic covers genital herpes (chiefly HSV-2, with HSV-1 increasingly a cause of genital infection), its latency and recurrence, and asymptomatic shedding; HIV transmission, natural history, and the impact of treatment; the epidemiological link between HSV and HIV acquisition; and biomedical prevention such as pre-exposure prophylaxis. It is descriptive reference material, not individualized treatment guidance.

Core questions

  • Why do herpes simplex infections recur and persist for life?
  • How does asymptomatic viral shedding sustain HSV transmission?
  • How does genital herpes increase the risk of acquiring and transmitting HIV?
  • What biomedical strategies, such as pre-exposure prophylaxis, reduce HIV transmission?

Key concepts

  • HSV-1 and HSV-2
  • Viral latency and reactivation
  • Asymptomatic (subclinical) shedding
  • Recurrent genital lesions
  • HSV–HIV epidemiological synergy
  • HIV natural history and CD4 decline
  • Antiretroviral therapy and viral suppression
  • Pre-exposure prophylaxis (PrEP)

Mechanisms

After initial genital infection, herpes simplex virus establishes lifelong latency in sensory ganglia and periodically reactivates, producing recurrent lesions and, importantly, asymptomatic shedding that transmits the virus even without visible disease. Genital ulceration and mucosal inflammation from HSV disrupt epithelial barriers and recruit susceptible immune cells, which is one mechanism by which genital herpes increases HIV acquisition and transmission. HIV itself infects and depletes CD4 T-cells, progressively impairing immunity unless suppressed by antiretroviral therapy. The same antiretroviral agents, taken before exposure as pre-exposure prophylaxis, can markedly reduce the risk of HIV acquisition.

Clinical relevance

Understanding the chronicity of HSV, the role of asymptomatic shedding, and the HSV–HIV link is central to appraising counselling, prevention, and biomedical-prophylaxis evidence relevant to adolescents. This entry describes the infections and population-level prevention strategies for reference purposes and does not provide diagnostic or treatment recommendations for any individual.

Epidemiology

Genital herpes is highly prevalent worldwide and largely transmitted by people unaware they are infected, owing to subclinical shedding, as reviewed by Gupta and colleagues. HIV remains a major infection among adolescents and young adults in many settings, and randomized evidence such as the trial by Baeten and colleagues established that antiretroviral pre-exposure prophylaxis substantially reduces HIV acquisition among at-risk populations.

History

The recognition of HSV latency and of asymptomatic shedding reshaped understanding of how genital herpes spreads. For HIV, the trajectory from a uniformly fatal infection in the 1980s to a manageable chronic condition followed the development of combination antiretroviral therapy, and landmark trials in the 2010s then established antiretroviral pre-exposure prophylaxis as an effective prevention tool, broadening the prevention toolkit relevant to young people.

Debates

How should HIV pre-exposure prophylaxis be delivered to adolescents?
While trials establish that pre-exposure prophylaxis prevents HIV acquisition, questions of access, adherence support, confidentiality, and consent for adolescents make its delivery to young people an active programmatic and ethical discussion.

Related topics

Seminal works

  • gupta-2007
  • baeten-2012

Frequently asked questions

Can genital herpes be transmitted when there are no symptoms?
Yes. Herpes simplex virus is frequently shed from the genital tract without visible lesions, so transmission can occur from people who have no symptoms and may not know they are infected.
How are herpes and HIV linked?
Genital herpes causes mucosal ulceration and inflammation that increase both susceptibility to acquiring HIV and the efficiency of transmitting it, which is why the two infections are epidemiologically connected.

Methods for this concept

Related concepts